Drug companies and clinical trials
(Redirected from Drug companies and clincial trials)
Jump to navigation
Jump to search
In July 2007 the St. Petersburg Times reported on the case of Accentia BioPharmaceuticals, a small drug company attempting top develop a treatment for sinusitis, SinuNase. To research the drug Accentia attracted PPD Inc. as a shareholder. A year later PPD also got the job of running the trials on the safety and effectiveness of SinuNase.
"If the PPD-run trials result in the drug being approved by the Food and Drug Administration, financially strapped Accentia will be on its way to tapping a billion-dollar market of folks with chronic sinusitis. And PPD will get 14 percent of the royalties. Is that a conflict of interest? The FDA doesn't think so," wrote St. Petersburg Times reporter Kris Hundley. [1]
Other SourceWatch Resources
References
- ↑ Kris Hundley, "Companies run trials of drugs they invest in: Critics say a conflict of interest couldn't be more clear, but the FDA doesn't think so", St. Petersburg Times, July 1, 2007.
| This article is a stub. You can help by expanding it. |
